{"title":"抗生素耐药性是一个医学问题","authors":"R. S. Kozlov, A. Y. Kuzmenkov, A. G. Vinogradova","doi":"10.31857/s0869587324010033","DOIUrl":null,"url":null,"abstract":"The growth and spread of antimicrobial resistance (AMR) is one of the main threats to the healthcare system. Currently, along with the development of new antimicrobial drugs (AMPs) the basic approach to countering the spread of AMR is the rational use of existing medicines. Selection of the optimal drug taking into account its activity, doses, frequency and route of administration are the basis of rational antimicrobial therapy. However, due to widespread availability of AMR, availability of up-to-date information on activity of AMP is extremely important. Therefore, monitoring of antibiotic resistance is a key activity to ensure providing the evidence base on which antimicrobial formularies should be drawn up drugs and treatment protocols. In the solution of these problems in the Russian Federation active role plaies the Methodological Verification Center on Antimicrobial Resistance – Reference center for clinical pharmacology, created on the basis of the Research Institute of Antimicrobial Chemotherapy of the Smolensk State Medical University of the Ministry of Health of Russian Federation.","PeriodicalId":344486,"journal":{"name":"Вестник Российской академии наук","volume":" 9","pages":""},"PeriodicalIF":0.0000,"publicationDate":"2024-07-04","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":"{\"title\":\"Antibiotic resistance as a medical problem\",\"authors\":\"R. S. Kozlov, A. Y. Kuzmenkov, A. G. Vinogradova\",\"doi\":\"10.31857/s0869587324010033\",\"DOIUrl\":null,\"url\":null,\"abstract\":\"The growth and spread of antimicrobial resistance (AMR) is one of the main threats to the healthcare system. Currently, along with the development of new antimicrobial drugs (AMPs) the basic approach to countering the spread of AMR is the rational use of existing medicines. Selection of the optimal drug taking into account its activity, doses, frequency and route of administration are the basis of rational antimicrobial therapy. However, due to widespread availability of AMR, availability of up-to-date information on activity of AMP is extremely important. Therefore, monitoring of antibiotic resistance is a key activity to ensure providing the evidence base on which antimicrobial formularies should be drawn up drugs and treatment protocols. In the solution of these problems in the Russian Federation active role plaies the Methodological Verification Center on Antimicrobial Resistance – Reference center for clinical pharmacology, created on the basis of the Research Institute of Antimicrobial Chemotherapy of the Smolensk State Medical University of the Ministry of Health of Russian Federation.\",\"PeriodicalId\":344486,\"journal\":{\"name\":\"Вестник Российской академии наук\",\"volume\":\" 9\",\"pages\":\"\"},\"PeriodicalIF\":0.0000,\"publicationDate\":\"2024-07-04\",\"publicationTypes\":\"Journal Article\",\"fieldsOfStudy\":null,\"isOpenAccess\":false,\"openAccessPdf\":\"\",\"citationCount\":\"0\",\"resultStr\":null,\"platform\":\"Semanticscholar\",\"paperid\":null,\"PeriodicalName\":\"Вестник Российской академии наук\",\"FirstCategoryId\":\"1085\",\"ListUrlMain\":\"https://doi.org/10.31857/s0869587324010033\",\"RegionNum\":0,\"RegionCategory\":null,\"ArticlePicture\":[],\"TitleCN\":null,\"AbstractTextCN\":null,\"PMCID\":null,\"EPubDate\":\"\",\"PubModel\":\"\",\"JCR\":\"\",\"JCRName\":\"\",\"Score\":null,\"Total\":0}","platform":"Semanticscholar","paperid":null,"PeriodicalName":"Вестник Российской академии наук","FirstCategoryId":"1085","ListUrlMain":"https://doi.org/10.31857/s0869587324010033","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"","JCRName":"","Score":null,"Total":0}
引用次数: 0
摘要
抗菌药耐药性(AMR)的增长和蔓延是医疗系统面临的主要威胁之一。目前,在开发新型抗菌药物(AMPs)的同时,应对 AMR 扩散的基本方法是合理使用现有药物。根据药物的活性、剂量、给药频率和途径选择最佳药物是合理抗菌治疗的基础。然而,由于 AMR 的广泛存在,提供有关 AMP 活性的最新信息极为重要。因此,对抗生素耐药性的监测是一项关键工作,以确保为制定抗菌药物目录和治疗方案提供证据基础。在解决这些问题的过程中,俄罗斯联邦抗菌药物耐药性方法验证中心(临床药理参考中心)发挥了积极作用,该中心是在俄罗斯联邦卫生部斯摩棱斯克国立医科大学抗菌药物化疗研究所的基础上建立的。
The growth and spread of antimicrobial resistance (AMR) is one of the main threats to the healthcare system. Currently, along with the development of new antimicrobial drugs (AMPs) the basic approach to countering the spread of AMR is the rational use of existing medicines. Selection of the optimal drug taking into account its activity, doses, frequency and route of administration are the basis of rational antimicrobial therapy. However, due to widespread availability of AMR, availability of up-to-date information on activity of AMP is extremely important. Therefore, monitoring of antibiotic resistance is a key activity to ensure providing the evidence base on which antimicrobial formularies should be drawn up drugs and treatment protocols. In the solution of these problems in the Russian Federation active role plaies the Methodological Verification Center on Antimicrobial Resistance – Reference center for clinical pharmacology, created on the basis of the Research Institute of Antimicrobial Chemotherapy of the Smolensk State Medical University of the Ministry of Health of Russian Federation.